SORCS3: A Protein Involved in Pain, Anxiety and Neurotransmission

Target Name: SORCS3

NCBI ID: G22986

SORCS3

SORCS3: A Protein Involved in Pain, Anxiety and Neurotransmission

SORCS3 (SORCS receptor 3) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and muscle. It is a member of the SORCS family of G protein-coupled receptors, which are a subfamily of the large superfamily of G protein-coupled receptors (GPCRs). GPCRs are a diverse family of transmembrane proteins that play important roles in various physiological processes, including sensory perception, neurotransmission, and hormone signaling.

SORCS3 is a 194 amino acid long protein that consists of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain is made up of a N-terminal伪 helix and a C-terminalserine/threonine phosphorylation site, while the transmembrane domain is made up of a transmembrane伪 helix and a 尾-sheet. The intracellular domain is made up of a 伪-helices and a 尾-sheet.

SORCS3 is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and muscle. It is highly expressed in the pancreas, which is responsible for producing and secreting insulin to regulate blood sugar levels. It is also expressed in the brain, where it is involved in the regulation of neurotransmitter signaling. SORCS3 is also expressed in other tissues, including the heart, lungs, liver, and kidney.

SORCS3 is a protein that is involved in various physiological processes, including sensory perception and neurotransmission. It is involved in the regulation of pain signaling, anxiety and depression, and neurotransmission. SORCS3 is also involved in the regulation of the immune system, which is important for protecting the body against infection and disease.

SORCS3 is a potential drug target for various diseases, including pain, anxiety and depression, and neurotransmission disorders. It is also a potential biomarker for these diseases. SORCS3 has been shown to be involved in the regulation of pain signaling, which is a major contributor to the development and maintenance of pain disorders. SORCS3 has also been shown to be involved in the regulation of anxiety and depression, which are common disorders that affect millions of people worldwide. SORCS3 has also been shown to be involved in the regulation of neurotransmission, which is important for the function of the nervous system.

SORCS3 is a protein that is involved in various physiological processes, including sensory perception and neurotransmission. It is a potential drug target and biomarker for various diseases, including pain, anxiety and depression, and neurotransmission disorders. Further research is needed to fully understand the role of SORCS3 in these processes and to develop effective treatments for these diseases.

Protein Name: Sortilin Related VPS10 Domain Containing Receptor 3

The "SORCS3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SORCS3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets